Back to search
HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which HER2-expressing or HER2-mutated Locally or Metastatic Solid Tumors trials you may qualify forTo evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-4602 in subjects with HER2-expressing or HER2-mutated locally advanced or met…
Open-label, Phase I-II, first-in-human (FIH) study for A166 monotherapy in HER2-expressing or amplified patients who progressed on or did not respond to availab…